(Q34482036)

2 August 2017

1 reference

title

Valacyclovir in the treatment of genital herpes and herpes zoster (English)

1 reference

2 August 2017

0 references

1 reference

David A Baker

1

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 January 2002

1 reference

Expert Opinion on Pharmacotherapy

2 August 2017

published in

1 reference

2 August 2017

volume

3

1 reference

2 August 2017

issue

1

1 reference

2 August 2017

page(s)

51-58

1 reference

Improving the care of patients with genital herpes

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.1.51

Valaciclovir: a review of its long term utility in the management of genital herpes simplex virus and cytomegalovirus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.1.51

Valaciclovir versus acyclovir in the treatment of first-episode genital herpes infection. Results of an international, multicenter, double-blind, randomized clinical trial. The Valaciclovir International Herpes Simplex Virus Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.1.51

A randomized, placebo-controlled comparison of oral valacyclovir and acyclovir in immunocompetent patients with recurrent genital herpes infections. The Valaciclovir International Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.1.51

Valaciclovir for the suppression of recurrent genital herpes simplex virus infection: a large-scale dose range-finding study. International Valaciclovir HSV Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.1.51

21 January 2018

Identifiers

DOI

10.1517/14656566.3.1.51

1 reference

2 August 2017

1 reference